Upcoming events – Avadel takes on Jazz and Axovant awaits early results

cafead

Administrator
Staff member
  • cafead   Feb 14, 2020 at 10:42: AM
via Data will soon show whether Avadel’s FT218 is more convenient than Jazz’s Xyrem, while Axovant will be looking for a dose response with its Parkinson’s gene therapy.

article source